Gene Therapy Immunogenicity Summit
Evvnt Promotion / evvnt
Archivio
18.10.2022 - 20.10.2022 Embassy Suites by Hilton Boston at Logan Airport, 207 Porter St, 02116 Boston, Massachusetts, USA
Time: 8:00 AM - 6:00 PM
Temi della conferenza
The 3rd Annual Gene Therapy Immunogenicity Summit is industry’s definitive forum enabling you to better modulate, measure and predict the immune response to your gene therapy candidate.
In the context of ever-increasing gene therapy clinical activity and uncertainty around challenges posed by immune responses to delivery, this summit will unite large pharma and innovative biotech’s to ensure that you’re up to speed on the latest approaches to evaluate and overcome pre-existing immunity.
The 3rd Annual Gene Therapy Immunogenicity Summit is industry’s definitive forum enabling you to better modulate, measure and predict the immune response to your gene therapy candidate.
In the context of ever-increasing gene therapy clinical activity and uncertainty around challenges posed by immune responses to delivery, this summit will unite large pharma and innovative biotech’s to ensure that you’re up to speed on the latest approaches to evaluate and overcome pre-existing immunity.
Professional congress organizer (PCO)
Hanson Wade
Hanson Wade
Informazioni ed Iscrizioni:
https://go.evvnt.com/1204401-2?pid=4832
Ms. Emily Birt
Medicina General
Lingua
Inglese
Inglese
Quote del Congresso
USD 2599.00 - USD 4896.00
USD 2599.00 - USD 4896.00
I partecipanti attesi
1000
1000
Contatto organizzatori
83 Great Titchfield Street
W1W 6RH London
United Kingdom
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Noi, Going International, siamo un’azienda che si è scelta come obiettivo di rendere acessibile la formazione a una grandissima quantità di persone, oltrepassanddo i confini geografici e sociali."
